X-linked myotubular myopathy (XLMTM) is a severe and fatal congenital
myopathy for which there is currently no treatment. As part of an
international group of scientists studying treatments for this disease,
Dr. Mike Lawlor (the neuropathologist serving Children's Hospital of
Wisconsin) was recently featured on Milwaukee's WTMJ 10 o'clock news for
his part in the work. The piece is quite touching. Mike conveys a sense of urgency in finding a cure for this disease because he has gotten to
know several children stricken with XLMTM, and even has pictures of many of the little tikes up on his office wall. Mike has presented his work on XLMTM at the past
several AANP meetings, including trials using myostatin inhibition,
targeted enzyme replacement therapy, and gene therapy on animal models
of this disease. The work in this story relates to the gene therapy
trial that was
recently published in Science Translational Medicine (depicted on the left), for which Mike
was the study pathologist. A photomicrograph from the article was even featured on the front page of that prestigious journal. He is continuing to work on these treatment
options in preparation for translation to human clinical trials that
will occur over the next few years. Congratulations to Dr. Mike Lawlor for splendidly representing neuropathologists in both the lay media and academic press.
I discuss issues pertaining to the practice of neuropathology -- including nervous system tumors, neuroanatomy, neurodegenerative disease, muscle and nerve disorders, ophthalmologic pathology, neuro trivia, neuropathology gossip, job listings and anything else that might be of interest to a blue-collar neuropathologist.
Subscribe to:
Post Comments (Atom)
Neuropathology Blog is Signing Off
Neuropathology Blog has run its course. It's been a fantastic experience authoring this blog over many years. The blog has been a source...
-
Shannon Curran, MS with her dissection Shannon Curran, a graduate student in the Modern Human Anatomy Program at the University of Co...
-
Neuropathology Blog has run its course. It's been a fantastic experience authoring this blog over many years. The blog has been a source...
No comments:
Post a Comment